1. 1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. (September 2015) Authors: Kienle, D.; Winterhalder, R.; Koeberle, D.; Horber, D.; Kueng, M.; Saletti, P.; Helbling, D.; Bastian, S.; Dietrich, D.; Baertschi, D.; Pilop, C.; Von Moos, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗